Laparoscopic hepatojejunostomy for biliary atresia.
Shu-Li Liu1, Long Li, Wei Cheng
1Department of Pediatric Surgery, Peking University First Hospital, Beijing, China.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|November 4, 2008
Summary
Laparoscopic hepatojejunostomy is a feasible, safe, and effective surgical approach for infants with types I and II biliary atresia (BA). This minimally invasive technique offers good outcomes, with jaundice resolving and bilirubin levels normalizing in most patients.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Minimally Invasive Surgery
Background:
- Biliary atresia (BA) is a serious neonatal liver disease requiring surgical intervention.
- Types I and II BA involve correctable extrahepatic bile duct cysts.
- Early diagnosis and treatment are crucial for improving outcomes in BA.
Purpose of the Study:
- To assess the feasibility and safety of laparoscopic hepatojejunostomy for treating types I and II biliary atresia.
- To evaluate the clinical outcomes and recovery patterns following this minimally invasive procedure.
Main Methods:
- A prospective study of 10 infants (6 female, 4 male) with types I or II BA, aged 23–160 days.
- All patients underwent laparoscopic cyst excision and Roux-en-Y hepatojejunostomy.
- Follow-up median of 26 months to assess outcomes.
Main Results:
- The median operative time was 3.0 hours with minimal blood loss.
- Postoperative recovery was rapid: flatus in 18 hours, oral intake in 20 hours, and normal stools by 3 days.
- Jaundice resolved by postoperative day 10, with bilirubin normalization in 6 cases within 3 weeks; one patient had persistent hyperbilirubinemia.
Conclusions:
- Laparoscopic hepatojejunostomy is a feasible, safe, and effective surgical option for infants with types I and II biliary atresia.
- The minimally invasive approach facilitates a quicker recovery and good clinical outcomes.
- This technique represents a viable alternative to open surgery for select BA cases.
